Dergiler / Düşünen Adam - Psikiyatri ve Nörolojik Bilimler Dergisi / 2018 / Cilt: 31 - Sayı: 4

Acute Dystonia Caused by Clomipramine: a Case Report

Klomipraminin neden olduğu akut distoni: Bir olgu sunumu

Sayfa
396–399
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

We wish to draw attention to this rare side effect of clomipramine and to contribute to the literature by presenting a case of acute dystonia on the 5 th day of clomipramine treatment in a 19-year-old male patient.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Drug-induced acute dystonia is a movement disorder that occurs most often with neuroleptics, though there are many drugs in its etiology.
📊
Temel Bulgular & Veri:The exact mechanism of antidepressant-associated extrapyramidal side effects (EPS) is not known.
💡
Sonuç & Katkı:We wish to draw attention to this rare side effect of clomipramine and to contribute to the literature by presenting a case of acute dystonia on the 5 th day of clomipramine treatment in a 19-year-old male patient.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Drug-induced acute dystonia is a movement disorder that occurs most often with neuroleptics, though there are many drugs in its etiology. The exact mechanism of antidepressant-associated extrapyramidal side effects (EPS) is not known. However, hypotheses including inhibition of dopaminergic function in the nigrostriatal pathway, impaired balance between dopaminergic, serotonergic, noradrenergic or cholinergic activity, and serotonergic inhibition of dopaminergic functions in the striatum leading to extrapyramidal side effects have been suggested. The number of cases with acute dystonia during clomipramine use is low. We wish to draw attention to this rare side effect of clomipramine and to contribute to the literature by presenting a case of acute dystonia on the 5 th day of clomipramine treatment in a 19-year-old male patient.

Abstract

İlaç kullanımıyla ortaya çıkan akut distoni, etiyolojisinde birçok ilacın olduğu ama en sık nöroleptiklerle ortaya çıkan bir hareket bozukluğudur. Antidepresan kullanımı ile ortaya çıkan ekstrapiramidal yan etkilerin oluş mekanizması tam olarak bilinmemektedir. Ancak, dopaminerjik fonksiyonların nigrostriatal yolakta inhibe edilmesi, dopaminerjik, serotonerjik, noradrenerjik veya kolinerjik aktivite arasındaki dengenin bozulması, striatumda dopaminerjik fonksiyonların serotonin tarafından inhibisyonunun ekstrapiramidal yan etkilere yol açması ileri sürülen hipotezlerdendir. Literatürde klomipramin kullanımı sonrasında akut distoni gelişen vaka sayısı nadirdir. Biz 19 yaşındaki erkek hastamızda klomipramin kullanımının 5. gününde ortaya çıkan akut distoni gelişimi olgusunu sunarak klomipraminin nadir görülen bu yan etkisine dikkat çekmek ve literatüre katkıda bulunmak istedik.

🔖

Bu Makaleye Atıf Yap

BAYKARA, S., TABARA, M. F., KORKMAZ, S., ATMACA, M. (2018). Acute Dystonia Caused by Clomipramine: a Case Report. Düşünen Adam - Psikiyatri ve Nörolojik Bilimler Dergisi, Cilt: 31 - Sayı: 4, 396–399. https://ajindex.com/articles/161330

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (2)

  1. Ozturk MO. Mental Health and Mental Disorders. Ankara: Nobel Medicine Bookstores, 2015. (Turkish) Domínguez-Morán JA, Callejo JM, Fernández-Ruiz LC, Martínez-Castrillo JC. Acute paroxysmal dystonia induced by fluoxetine. Mov Disord 2001; 16:767-769. [CrossRef] Gill HS, DeVane CL, Risch SC. Extrapyramidal symptoms associated with cyclic antidepressant treatment: a review of the literature and consolidating hypotheses. J Clin Psychopharmacol 1997; 17:377-389. [CrossRef] Madhusoodanan S, Alexeenko L, Sanders R, Brenner R. Extrapyramidal symptoms associated with antidepressants – a review of the literature and an analysis of spontaneous reports. Ann Clin Psychiatry 2010; 22:148-156. Schillevoort I, van Puijenbroek EP, de Boer A, Roos RA, Jansen PA, Leufkens HG. Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case control study using spontaneous reports. Int Clin Psychopharmacol 2002; 17:75-79. [CrossRef] Najjar E, Price LH. Citalopram and dystonia. J Am Acad Child Adolesc Psychiatry 2004; 43:8-9. [CrossRef] Baykara S, Korkmaz S, Taşcı G, Kaya S, Atmaca M. Edema induced with clomipramine. Journal of Mood Disorders (JMOOD) 2016; 6:238-241. [CrossRef] (Turkish) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). Fifth ed., Washington DC: American Psychiatric Pub., 2013.
  2. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30:239-245. [CrossRef] Hedenmalm K, Guzey C, Dahl ML, Yue QY, Spigset O. Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms. J Clin Psychopharmacol 2006; 26:192- 197. [CrossRef] Shin HW, Chung SJ. Drug induced parkinsonism. J Clin Neurol 2012; 8:15-21. [CrossRef] Robottom BJ, Shulman LM, Weiner W.J. Drug-induced movement disorders: emergencies and management. Neurol Clin 2012; 30:309-320. [CrossRef] Bondon-Guitton E, Perez-Lloret S, Bagheri H, Brefel C, Rascol O, Montastruc JL. Drug-induced parkinsonism: a review of 17 years’ experience in a regional pharmacovigilance center in France. Mov Disord 2011; 26:2226-2231. [CrossRef] Cunningham Owens DG. A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs. Cambridge: Cambridge University Press, 1999. [CrossRef] Pierre JM